The present technology relates to implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. For example, selected embodiments of the present technology comprise shock absorbing structures that can inhibit dislodgement of the device relative to the aneurysm.
Many of the currently available surgical approaches for closing openings and repairing defects in anatomical lumens and tissues (e.g., blood vessels), septal defects, and other types of anatomical irregularities and defects are highly invasive. Surgical methods for clipping brain aneurysms, for example, require opening the skull, cutting or removing overlying brain tissue, clipping and repairing the aneurysm from outside the blood vessel, and then reassembling tissue and closing the skull. The risks related to anesthesia, bleeding, and infection associated with these types of procedures are high, and tissue that is affected during the procedure may or may not survive and continue functioning.
Minimally invasive techniques for treating aneurysms are accordingly highly desirable. In general, such minimally invasive therapeutic techniques help prevent material that collects or forms in the aneurysm cavity from entering the bloodstream and help prevent blood from entering and collecting in the aneurysm. This is often accomplished by introducing various materials and devices into the aneurysm. For example, implantable vaso-occlusive metallic structures are well known and commonly used. Many conventional vaso-occlusive devices have helical coils constructed from a shape memory material or noble metal that forms a desired coil configuration upon exiting the distal end of a delivery catheter. The function of the coil is to fill the space formed by an anatomical defect and to facilitate the formation of an embolus with the associated allied tissue. Multiple coils of the same or different structures may be implanted serially in a single aneurysm or other vessel defect during a procedure. Implantable framework structures are also used in an attempt to stabilize the wall of the aneurysm or defect prior to insertion of filling material such as coils. It is important to accurately implant vaso-occlusive devices within the internal volume of a cavity and to maintain the devices within the internal volume of the aneurysm. Migration or projection of a vaso-occlusive device from the cavity may interfere with blood flow or nearby physiological structures and can pose a serious health risk.
In addition to the difficulties of delivering implantable occlusion devices, some types of aneurysms are challenging to treat because of the particularities of the treatment site and/or the structural features of the aneurysm itself. Wide-neck aneurysms, for example, are known to present particular difficulty in the placement and retention of vaso-occlusive coils. Aneurysms at sites of vascular bifurcation are another example where the anatomical structure poses challenges to methods and devices that are effective in treating the typical sidewall aneurysms. It is therefore challenging to position conventional implantable devices during deployment, prevent shifting or migration of such devices after deployment, and preserve blood flow in neighboring vessels following deployment.
The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology comprise shock absorbing structures that can inhibit dislodgement of the device relative to the aneurysm. The following description provides many specific details for a thorough understanding of, and enabling description for, embodiments of the disclosure. Well-known structures, systems, and methods often associated with such systems have not been shown or described in detail to avoid unnecessarily obscuring the description of the various embodiments of the disclosure. In addition, those of ordinary skill in the relevant art will understand that additional embodiments may be practiced without several of the details described below.
The closure structure 152 can be a frame, scaffold, or other structure that at least partially occludes the neck N of the aneurysm A to prevent embolic coils (shown in
In multiple device embodiments, the aneurysm device 150 may be deployed such that it is anchored along a specific portion of the neck N of the aneurysm A. As shown in
A proximally-extending portion 232 of the closure structure 152 may be coupled to a distally-extending portion 222 of the shock absorbing structure 101 by an attachment feature 230. In some embodiments, the attachment feature 230 comprises a solder attachment. In further embodiments, however, other attachment mechanisms can be used. The flexibility provided by the shock-absorbing assembly 220 and the attachment feature 230 is expected to inhibit movement of the supplemental stabilizer 153 relative to a vessel wall and help prevent movement in the blood vessel from dislodging the aneurysm device 150 after deployment.
Referring now to
An aneurysm device endovascularly deliverable to a site proximate to an aneurysm near a parent artery with bifurcating downstream branches, the aneurysm device comprising:
The aneurysm device of example 1 wherein the shock absorbing structure comprises a spring.
The aneurysm device of example 2 wherein the spring comprises a leaf spring having a first spring arm and a second spring arm, and wherein the first and second spring aims at least partially surround an aperture.
The aneurysm device of example 3 wherein the first spring arm and the second spring aim extend laterally from at least one of the closure structure or the supplemental stabilizer.
The aneurysm device of example 2 wherein the supplemental stabilizer is configured to move proximally, distally, and/or laterally relative to the closure structure as the shock absorbing assembly exhibits spring movement.
The aneurysm device of example 1, further comprising an attachment feature configured to couple the closure structure to the shock absorbing structure.
The aneurysm device of example 6 wherein the attachment feature comprises hardened solder.
The aneurysm device of example 1 wherein the shock absorbing structure comprises a moveable junction between the closure structure and the supplemental stabilizer.
A system for treating an aneurysm, the system comprising:
The system of example 9 wherein the spring comprises a junction connecting the distal framework portion and the proximal support framework.
The system of example 9 wherein the spring comprises a leaf spring.
The system of example 9 wherein the distal framework portion comprises a set of distal struts forming at least one quadrilateral form with first and second longitudinal junctions, and wherein the system further comprises a barrier covering at least a portion of the distal struts.
The system of example 9 wherein the barrier comprises a membrane configured to enhance a separation between a cavity of the aneurysm and the parent artery.
A method of treating an aneurysm located at a site within a blood vessel, the method comprising:
The method of example 14 wherein absorbing movement of the framework comprises dampening movement of the framework relative to a blood vessel wall with the shock-absorbing structure.
The method of example 14 wherein absorbing movement of the framework comprises absorbing movement with a spring connecting the distal portion and the proximal portion.
The method of example 14 wherein absorbing movement of the framework comprises inhibiting dislodgement of the framework relative to the aneurysm.
The method of example 14 wherein absorbing movement of the framework comprises absorbing movement with a leaf spring.
The method of example 14 wherein absorbing movement of the framework comprises absorbing movement of the distal portion relative to the proximal portion.
The method of example 14, further comprising at least partially occluding the aneurysm with a barrier membrane coupled to the distal portion.
The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments. In particular, the clot removal devices described above with reference to particular embodiments can include one or more additional features or components, or one or more of the features described above can be omitted.
From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, B all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
The present application claims the benefit of pending U.S. Provisional Patent Application No. 61/493,348, filed on Jun. 3, 2011, and incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2012/040552 | 6/1/2012 | WO | 00 | 4/30/2014 |
Number | Date | Country | |
---|---|---|---|
61493348 | Jun 2011 | US |